-
A phase II study tests a new drug for patients with advanced thyroid cancer
-
Brigitte Widemann leads early-phase trial that shows drug shrinks NF1 tumors
-
Novel target for high-risk neuroblastoma identified in pre-clinical research
-
Molecules discovered that block cancer-associated microRNAs
-
#clinicaltrial tests new drug to treat metastatic or advanced #thyroidcancer https://t.co/tGIwnoNXN0 https://t.co/sclQBGDTwI
-
Apply now for the 1-year #immunotherapy fellowship co-spons w/ @sitcancer https://t.co/X3OUE9aMJK https://t.co/2Gi6JM04Ki
-
#CCRAdvance Recombinant immunotoxins that target T cell leukemias are immunogenic in patients… https://t.co/qOrcq8m6xJ
-
RT @gulleyj1: When we all stand together cancer doesn't stand a chance. #SU2C @NCIResearchCtr @SU2C https://t.co/81fJTEtGDR
-
RT @NCIDrDoug: New @TCGAupdates research could advance efforts to find drugs targeting #cervicalcancer genomes & #HPV genes… https://t.co/vM110Ch6om
-
Calling all web developers w/strong communication skills. Our Frederick office is #NowHiring. Apply here:… https://t.co/QFELm7zop8
-
RT @theNCI: There are different types of treatment for patients with #cervicalcancer. An overview: https://t.co/Pu7ARYSFnx… https://t.co/5nE4nU57tb